How COVID-19 Is Reshaping the Global Ventilator Market

Ventilators offer critical care support to patients who are unable to breathe on their own. The recently discovered novel coronavirus strain, also known as COVID-19, has led to a rapid rate of respiratory infections and deaths globally. Therefore, a dramatic rise in the demand for ventilators is currently being witnessed, owing to the severe respiratory illness caused by the disease.

Topics: Healthcare Medical Devices Industry Insights

$71 Billion U.S. Weight Loss Industry Pivots to Survive Pandemic

The total U.S. weight loss market hit a new peak in 2019, growing to $78 billion. However, that growth came to a halt when the Coronavirus hit in March, shutting the doors of weight loss centers, doctors’ offices, clinics, and other businesses for 8-10 weeks. As a result, the value of the market is forecast to decline by 9% this year.

Topics: Food & Beverage Pharmaceuticals Healthcare Industry Insights

The Global Respiratory Masks Market Is Projected to Grow 22.9% by 2023

The global respiratory masks (N95 respirators, surgical masks, and others) market will grow from 14,600 million units in 2019 to 33,360.9 million units in 2023 at a compound annual growth rate (CAGR) of 22.9%, according the Respiratory Masks Global Market Opportunities And Strategies To 2030 report by The Business Research Company.

Topics: Healthcare Medical Devices Industry Insights

How Artificial Intelligence Is Intensifying the Fight Against COVID-19

It is a major cause for concern that there is no proper vaccination and official treatment available that can help mitigate the coronavirus pandemic so far. Thus, it is imperative for researchers and scientists to explore different approaches and devise ways to counter this global health crisis.

Topics: Software & Enterprise Computing Pharmaceuticals Healthcare Industry Insights

Infographic: Acute Kidney Injury (AKI) Market Insights

Acute Kidney Injury (AKI) is a condition characterized by minor or complete loss of kidney function due to a sudden injury to kidneys. AKI is different from chronic kidney disease, wherein the kidney function is lost over a period of time.

Topics: Healthcare Industry Insights

Steady Growth of U.S. Fertility Clinics Industry Halted by Covid-19

The $6 billion fertility clinics and infertility services industry in the United States had been booming through 2019, thanks to growing demand from American couples that have delayed childbearing, more widespread acceptance of fertility treatment and usage by gay couples, improved success rates, a strong economy, and significant demand from medical tourists from Europe and China.

Topics: Healthcare Industry Insights

COVID-19 and Testing in the US:  Moving Forward

“Had [the US] done more testing from the very beginning and caught cases earlier,” said Dr. Nuzzo of Johns Hopkins, “we would be in a far different place.”

Topics: Diagnostics Healthcare Industry Insights

COVID-19: How It's Different from Previous Pandemics and How It's Impacting World Economies

In light of the ongoing COVID-19 (coronavirus) pandemic, it is imperative to understand the origin of this virus. Previously, such pandemics were often a result of the spread of viruses such as H1N1, H5N1, and Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV), among others.

Topics: Pharmaceuticals Healthcare Industry Insights

Pace of EUAs Increase as Molecular Diagnostics Vendors Submit COVID-19 Tests

Roche, Hologic, and Thermo Fisher Scientific are among the molecular diagnostic vendors that have received EUAs, or emergency use authorizations, for their tests for the novel coronavirus COVID-19.  

Topics: Diagnostics Healthcare Kalorama Information Industry Insights

The Market Implications of the Coronavirus Outbreaks

Global stocks fell on Monday, with declines in all 11 sectors of the S&P 500, as concerns grew over the rising threat of the coronavirus.

Coronavirus outbreaks have disrupted global supply chains linked to China. According to The Wall Street Journal, some economists estimate that a prolonged Chinese shutdown could cost up to $1 trillion in lost manufacturing output.

Topics: Pharmaceuticals Healthcare Industry Insights